Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 29. Antidepresivos y psicoestimulantes | No observations |
| Mexico. Cuadro Basico de Medicamentos - 2017 | 20. PSIQUIATRIA | No observations |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | N. SISTEMA NERVOSO | No observations |
| Chile. Formulario Nacional de Medicamentos. 2005 | 20.02. MEDICAMENTOS USADOS EN EL TRASTORNO DEL ANIMO | No observations |
| Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 28:16 Psychotherapeutic agents | No observations |
| Barbados. Barbados National Drug Formulary (BNDF) | 28.16.04.20 Selective Serotonin Reuptake Inhibitors | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 04.03.02 Selective Serotonin Reuptake Inhibitors | No observations |
| List | Section | Observation |
|---|---|---|
| Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 | Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC |
Others observations: INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS |
| List | Section | Observation |
|---|---|---|
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 04.03.02 Selective Serotonin Reuptake Inhibitors | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 24.2.1. Medicines used in depressive disorders | No observations |
| WHO Model List of Essential Medicines (2021) | 24.2.1. Medicines used in depressive disorders |
Age or weight restriction:
>8 years. This medicine requires a children care specialist. |
| PAHO Strategic Fund Medicine List | 13.2. Medicines used in mood disorders |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |
| Peru | 24.2.1 For Depressive Disorders | No observations |
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Cns Antidepressants - Ssri | No observations |
| WHO Model List of Essential Medicines (2021) | 2.3. Medicines for other common symptoms in palliative care |
Age or weight restriction:
>8 years |
| List | Section | Observation |
|---|---|---|
| Ecuador | Essential Medicines List - Ecuador | No observations |
| Haiti. National List of Essential Medicines | 24.02.01. Antidepressants |
Age or weight restriction:
> 8 yrs |
| List | Section | Observation |
|---|---|---|
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 02.03 ANTIDEPRESSANTS | No observations |
| Guyana. Essential Medicines List. 2020-2021 | 24.02.03. Selective Serotonin Re-uptake Inhibitors | No observations |
| Bahamas. Drug Formulary | 05.03. Antidepressants | No observations |
| List | Section | Observation |
|---|---|---|
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 02.03 ANTIDEPRESSANTS | No observations |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | N. SISTEMA NERVOSO | No observations |
| Paraguay. Lista de Medicamentos Esenciales. 2009 | 06. PSICOANALÉPTICOS | No observations |
| El Salvador - 2019 | PSICOANALÉPTICOS | No observations |
| Guyana. Essential Medicines List. 2020-2021 | 24.02.03. Selective Serotonin Re-uptake Inhibitors | No observations |
| Haiti. National List of Essential Medicines | 02.03 Medication for Other Common Symptoms in Palliative Care |
Age or weight restriction:
> 8 years |
| Barbados. Barbados National Drug Formulary (BNDF) | 28.16.04.20 Selective Serotonin Reuptake Inhibitors | No observations |
| Bahamas. Drug Formulary | 05.03. Antidepressants | No observations |
| Belize. National Drug Formulary | 24.02.01 Medicines used in depressive disorders | No observations |